Tag:

HIV

Latest Headlines

Latest Headlines

Indian drugmakers scramble to prevent shortages of HIV/AIDS meds

Some Indian companies that had put off production of HIV/AIDS meds while they waited for the government to sign contracts are now having to seriously ramp up because of shortages of some meds, Reuters reports.

HIV spikes reveal clues for vaccine development

New technology has allowed researchers to view HIV proteins in action, zooming in on so-called spikes that help the virus bind to cells it infects. The research puts scientists one step closer to a vaccine that could effectively prevent transmission of HIV and halt the spread of AIDS, an international epidemic.

Gates Foundation funds monkey study of new HIV vaccine

Swiss firm Mymetics is getting a boost from the Bill and Melinda Gates Foundation to conduct a key animal study for its HIV vaccine candidate at the Texas Biomedical Research Institute.

Once-rejected drugs in Gilead's Stribild get FDA nod to go it alone

Gilead has been seeking FDA approval for HIV drugs Tybost and Vitekta for a while now, but the agency dealt the drugmaker a setback with Complete Response Letter last year. Now, 17 months later, the two have passed muster.

How was HIV eradicated in one patient?

A new monkey study points to how a cancer treatment that the famous "Berlin patient" underwent may have resulted in HIV being eradicated in his body.

Monkey study reveals clues for HIV eradication

A new sheds light on three different factors that may have contributed to ridding HIV from the "Berlin patient."

HIV-fighting intravaginal ring research nets $20M from NIH

The U.S. National Institutes of Health devoted $20 million to develop an HIV drug-delivering intravaginal ring. The design of a successful ring is a priority in HIV research, and the sustained release of drugs the ring offers could eventually play a crucial role in HIV prevention in the developing world.

Seaweed-based suppository shows promise delivering antiretrovirals during sex

Researchers have designed a novel suppository for HIV antiretroviral delivery using the seaweed extract carrageenan. Almost half of the antiretroviral drug tenofovir diffused out of the delivery mechanism within the first two hours in an in vitro study testing the product in  water, vaginal simulant fluid and semen simulant fluid. 

Novel epitope for binding of HIV antibodies has major drug delivery implications

The discovery of a new HIV antibody highlights the need to create vaccines with trimeric delivery systems that resemble those found naturally, said Mark Connors, the research team's principal investigator and chief of the HIV-Specific Immunity Section.

Study: Old HIV pediatric vaccines might provide protection after all

Looking back on data from old pediatric HIV vaccine trials, researchers have found that two vaccines studied in the 1990s elicited a specific antibody response that was unknown at the time to be associated with HIV protection.